Cardiac Insight Reports Increased Cardea 20/20 ECG™ Sales to Screen Young Athletes for Conditions at Risk for Sudden Cardiac Arrest

BELLEVUE, Wash.–(BUSINESS WIRE)–Cardiac Insight, Inc., a healthcare innovator specializing in wearable electrocardiogram (ECG) cardiac sensors and proven automated ECG analysis that delivers innovative solutions and highly differentiated benefits to healthcare providers, clinicians, and patients, reported over a 70% surge in sales of its market leading Cardea 20/20 ECG™ technology in the first quarter of 2021.

Read the full story here.